ScholarLens Back to search
2019•Cardiovascular Disorders and MedicineOpen access

Cost effectiveness of proprotein convertase subtilisin/ kexin type 9 (PCSK9) inhibitors

Abdulhalim Jamal Kinsara

Open full text 0 citations

Abstract

The cost effectiveness of Proprotein Convertase Subtilisin/Kexin Type 9-(PCSK9) inhibitors was a global concern, we here elaborate on the analysis done in different countries and explore the unseen part of such analysis.A guideline-based approach with careful monitoring the use and delivered price will minimize the concern regarding cost effectiveness of PCSK9 inhibitors.

Open-access reader

About this research paper

What this paper is about

The cost effectiveness of Proprotein Convertase Subtilisin/Kexin Type 9-(PCSK9) inhibitors was a global concern, we here elaborate on the analysis done in different countries and explore the unseen part of such analysis.A guideline-based approach with careful monitoring the use and delivered price will minimize the concern regarding cost effectiveness of PCSK9 inhibitors.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The cost effectiveness of Proprotein Convertase Subtilisin/Kexin Type 9-(PCSK9) inhibitors was a global concern, we here elaborate on the analysis done in different countries and explore the unseen part of such analysis.A guideline-based approach with careful monitoring the use and delivered price will minimize the concern regarding cost effectiveness of PCSK9 inhibitors.

Key concepts: Kexin, Proprotein convertase, Subtilisin, PCSK9, Proprotein Convertases, Chemistry, LDL receptor, Biochemistry

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Cost effectiveness of proprotein convertase subtilisin/ kexin type 9 (PCSK9) inhibitors — Research Paper | ScholarLens